Steven Couldwell becomes CEO at Tissue Regenix

Company: Tissue Regenix Group Plc

Appointee: Steven Couldwell


United Kingdom

Steven Couldwell has become chief executive at Tissue Regenix Group Plc, having served as a non-executive director of the company since July 2013. He will help oversee the company’s expansion in the US. Mr Couldwell was most recently chief operating officer at Sanofi Biosurgery. He has also served as president of orthopaedics for Europe at Smith & Nephew Inc. He holds a bachelor’s degree in business studies from the University of Huddersfield in the UK.

Tissue Regenix announced the appointment on 2 November 2017.

Copyright 2017 Evernow Publishing Ltd